Page last updated: 2024-09-02

tadalafil and Weight Gain

tadalafil has been researched along with Weight Gain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aoki, Y; Inamura, S; Ito, H; Kobayashi, H; Nagase, K; Taga, M; Yokoyama, O; Zha, X1
Jia, H; Levine, MA; Qin, L; Tower, RJ; Wang, L1

Other Studies

2 other study(ies) available for tadalafil and Weight Gain

ArticleYear
Phosphodiesterase 5 inhibitor suppresses prostate weight increase in type 2 diabetic rats.
    Life sciences, 2022, Jun-01, Volume: 298

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin-Like Growth Factor I; Male; Phosphodiesterase 5 Inhibitors; Prostate; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Tadalafil; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Weight Gain

2022
Analysis of short-term treatment with the phosphodiesterase type 5 inhibitor tadalafil on long bone development in young rats.
    American journal of physiology. Endocrinology and metabolism, 2018, 10-01, Volume: 315, Issue:4

    Topics: Animals; Animals, Newborn; Bone and Bones; Bone Development; Cancellous Bone; Chondrocytes; Cortical Bone; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Epiphyses; Male; Natriuretic Peptide, C-Type; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tadalafil; Weight Gain; X-Ray Microtomography

2018